A detailed history of Assenagon Asset Management S.A. transactions in Innoviva, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 444,222 shares of INVA stock, worth $8.51 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
444,222
Previous 810,208 45.17%
Holding current value
$8.51 Million
Previous $13.3 Million 35.48%
% of portfolio
0.02%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$16.33 - $20.04 $5.98 Million - $7.33 Million
-365,986 Reduced 45.17%
444,222 $8.57 Million
Q1 2023

Apr 18, 2023

SELL
$10.73 - $13.6 $9.69 Million - $12.3 Million
-902,666 Reduced 52.7%
810,208 $9.11 Million
Q4 2022

Jan 12, 2023

SELL
$11.8 - $13.78 $2.24 Million - $2.62 Million
-190,058 Reduced 9.99%
1,712,874 $22.7 Million
Q3 2022

Oct 27, 2022

SELL
$11.61 - $15.22 $1.16 Million - $1.52 Million
-99,962 Reduced 4.99%
1,902,932 $22.1 Million
Q2 2022

Jul 27, 2022

BUY
$14.32 - $19.88 $12.9 Million - $17.9 Million
901,792 Added 81.9%
2,002,894 $29.6 Million
Q1 2022

Apr 25, 2022

BUY
$15.39 - $20.25 $14.2 Million - $18.7 Million
922,555 Added 516.7%
1,101,102 $21.3 Million
Q4 2021

Feb 01, 2022

BUY
$15.91 - $18.72 $2.84 Million - $3.34 Million
178,547 New
178,547 $3.08 Million
Q2 2021

Jul 15, 2021

SELL
$11.45 - $13.96 $811,472 - $989,359
-70,871 Closed
0 $0
Q1 2021

Apr 26, 2021

SELL
$11.06 - $12.87 $132 - $154
-12 Reduced 0.02%
70,871 $847,000
Q4 2020

Feb 01, 2021

BUY
$9.33 - $12.48 $661,338 - $884,619
70,883 New
70,883 $878,000
Q4 2019

Jan 17, 2020

SELL
$10.28 - $14.38 $3.88 Million - $5.43 Million
-377,613 Closed
0 $0
Q3 2019

Oct 16, 2019

BUY
$10.05 - $14.55 $3.8 Million - $5.49 Million
377,613 New
377,613 $3.98 Million
Q1 2019

Apr 26, 2019

SELL
$13.69 - $20.06 $2.7 Million - $3.96 Million
-197,516 Closed
0 $0
Q4 2018

Jan 23, 2019

BUY
$13.96 - $18.26 $2.76 Million - $3.61 Million
197,516 New
197,516 $3.45 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.33B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Assenagon Asset Management S.A. Portfolio

Follow Assenagon Asset Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.